Hacer İlke Önen

673 total citations
25 papers, 548 citations indexed

About

Hacer İlke Önen is a scholar working on Molecular Biology, Genetics and Reproductive Medicine. According to data from OpenAlex, Hacer İlke Önen has authored 25 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Reproductive Medicine. Recurrent topics in Hacer İlke Önen's work include Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). Hacer İlke Önen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). Hacer İlke Önen collaborates with scholars based in Türkiye. Hacer İlke Önen's co-authors include Ece Konaç, Abdullah Ekmekçi, Ebru Alp, Akın Yılmaz, Aydan Bırı, Sevda Menevşe, Adnan Menevşe, Ediz Yeşilkaya, Aysun Bıdecı and Peyamı Cınaz and has published in prestigious journals such as Gene, Experimental Biology and Medicine and Digestive Diseases and Sciences.

In The Last Decade

Hacer İlke Önen

24 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hacer İlke Önen Türkiye 13 231 162 162 98 88 25 548
Zühal Eroğlu Türkiye 15 192 0.8× 63 0.4× 87 0.5× 87 0.9× 64 0.7× 47 574
Luigi Tucci Italy 15 193 0.8× 151 0.9× 62 0.4× 95 1.0× 53 0.6× 34 731
Suresh Govatati India 18 296 1.3× 275 1.7× 80 0.5× 114 1.2× 47 0.5× 36 676
Jean‐Marc Lobaccaro France 10 184 0.8× 72 0.4× 61 0.4× 25 0.3× 106 1.2× 12 449
De‐Xin Yu China 11 185 0.8× 69 0.4× 123 0.8× 42 0.4× 40 0.5× 17 494
Xiaomei Zhang China 16 175 0.8× 49 0.3× 66 0.4× 46 0.5× 76 0.9× 35 477
Ryo Fukunishi Japan 15 187 0.8× 52 0.3× 120 0.7× 50 0.5× 102 1.2× 46 617
Morihiko Inamine Japan 16 156 0.7× 163 1.0× 43 0.3× 32 0.3× 136 1.5× 45 672
Haiyun Deng China 8 265 1.1× 51 0.3× 45 0.3× 24 0.2× 100 1.1× 11 419
Jean‐Marie Frenoux France 9 121 0.5× 102 0.6× 30 0.2× 63 0.6× 22 0.3× 13 502

Countries citing papers authored by Hacer İlke Önen

Since Specialization
Citations

This map shows the geographic impact of Hacer İlke Önen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hacer İlke Önen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hacer İlke Önen more than expected).

Fields of papers citing papers by Hacer İlke Önen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hacer İlke Önen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hacer İlke Önen. The network helps show where Hacer İlke Önen may publish in the future.

Co-authorship network of co-authors of Hacer İlke Önen

This figure shows the co-authorship network connecting the top 25 collaborators of Hacer İlke Önen. A scholar is included among the top collaborators of Hacer İlke Önen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hacer İlke Önen. Hacer İlke Önen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alp, Ebru, et al.. (2021). Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition. Molecular Biology Reports. 48(1). 475–489. 12 indexed citations
3.
Konaç, Ece, Ebru Alp, Hacer İlke Önen, et al.. (2019). Transcriptomic expression levels of the VHL, TIMP-3, and RASSF1A genes in renal tumors.. European review for medical and pharmacological sciences. 23(21). 9313–9320. 1 indexed citations
4.
Alp, Ebru, et al.. (2017). Effects of EF-24, RAD001, and paclitaxel on the expression profiles of apoptotic and anti-apoptotic genes. Journal of Cancer Research and Therapeutics. 13(2). 346–346.
5.
Yılmaz, Akın, Ebru Alp, Hacer İlke Önen, & Sevda Menevşe. (2016). Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel. Współczesna Onkologia. 1(1). 28–32. 12 indexed citations
6.
Doğan, İrem, et al.. (2016). Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model.. PubMed. 24(1). 2–12. 5 indexed citations
7.
Ekmekçi, Abdullah, Ece Konaç, & Hacer İlke Önen. (2014). Gene polymorphism and genetic susceptibility to cancer. Dspace Repository (Marmara Üniversitesi). 1 indexed citations
8.
Yaman, Emel, et al.. (2013). Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells. Genetics and Molecular Research. 12(4). 5405–5413. 4 indexed citations
9.
Önen, Hacer İlke, et al.. (2013). Enhanced Cisplatin Response with Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line. Turkiye Klinikleri Journal of Medical Sciences. 33(2). 478–484. 1 indexed citations
10.
Güner, Haldun, Mehmet Erdem, Ahmet Erdem, et al.. (2012). NLF2 gene expression in the endometrium of patients with implantation failure after IVF treatment. Gene. 508(1). 140–143. 9 indexed citations
11.
Konaç, Ece, et al.. (2011). Evaluation of the Effects of the Flavonoid Apigenin on Apoptotic Pathway Gene Expression on the Colon Cancer Cell Line (HT29). Journal of Medicinal Food. 14(10). 1107–1117. 60 indexed citations
12.
Ekmekçi, Abdullah, et al.. (2009). Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility. Journal of Assisted Reproduction and Genetics. 26(9-10). 503–510. 32 indexed citations
13.
Konaç, Ece, Ebru Alp, Hacer İlke Önen, et al.. (2009). Endometrial mRNA expression of matrix metalloproteinases, their tissue inhibitors and cell adhesion molecules in unexplained infertility and implantation failure patients. Reproductive BioMedicine Online. 19(3). 391–397. 29 indexed citations
14.
Konaç, Ece, Ediz Yeşilkaya, Akın Yılmaz, et al.. (2009). Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics. 26(4). 205–216. 106 indexed citations
15.
Ekmekçi, Abdullah, Ece Konaç, & Hacer İlke Önen. (2008). Gen polimorfizmi ve kansere yatkınlık. Marmara medical journal. 21(3). 282–295. 2 indexed citations
16.
Konaç, Ece, et al.. (2008). Single Nucleotide Polymorphisms in the Hypoxia-inducible Factor-1α (HIF-1α) Gene in Human Sporadic Breast Cancer. Archives of Medical Research. 39(3). 338–345. 45 indexed citations
17.
Konaç, Ece, et al.. (2007). An investigation of relationships between hypoxia-inducible factor-1α gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detection and Prevention. 31(2). 102–109. 57 indexed citations
19.
Demirağ, Mehmet Derya, Hacer İlke Önen, Meral Yirmibeş Karaoğuz, et al.. (2007). Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 52(12). 3399–3403. 28 indexed citations
20.
Konaç, Ece, et al.. (2006). The Relationship between Vascular Endothelial Growth Factor -634G greater than C Polymorphism and Ovarian, Cervical and Endometrial Cancers. 28(2). 99–107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026